Watkins D C, Northup J K, Malbon C C
Department of Pharmacological Sciences, State University of New York, Stony Brook 11794-8651.
J Biol Chem. 1989 Mar 5;264(7):4186-94.
The effects of pertussis toxin on the steady-state levels of G-protein alpha- and beta-subunits were investigated both in vitro and in vivo. The steady-state level Go alpha, a major substrate for pertussis toxin-catalyzed ADP-ribosylation, was unaltered by pertussis toxin treatment for periods up to 100 h for 3T3-L1 cells in culture or up to 3 days in vivo. In 3T3-L1 cells pertussis toxin treatment did not alter levels of Gs alpha-subunits; in S49 cells the level of Gs alpha-subunits declined moderately following by pertussis toxin treatment. The steady-state levels of G beta-subunits, in contrast, were found to decline to less than 50% of the normal cellular complement following pertussis toxin treatment in vitro and in vivo. Inhibitory control of adenylate cyclase, pertussis toxin-catalyzed ADP-ribosylation of Gi alpha and Go alpha, and the GTP-dependent shift in agonist-specific binding to beta-adrenergic receptors were attenuated or abolished within 5 h of pertussis toxin treatment, representing "early" effects of the toxin. Stimulatory regulation of adenylate cyclase, in contrast, displayed a progressive enhancement that was first observed 4 h after pertussis toxin treatment, increasing thereafter up until 100 h, the last time point measured. This progressive enhancement of the stimulatory pathway of adenylate cyclase was not manifest at the level of stimulatory receptors, since the Kd and Bmax for one such receptor, the beta-adrenergic receptor, were shown to be unaltered in toxin-treated cells. Furthermore, the potentiation of stimulation of adenylate cyclase was observed in cells stimulated by the beta-adrenergic agonist isoproterenol and PGE1 alike. The progressive enhancement of the stimulatory pathway correlated best with the decline in G beta-subunit levels that occurs following pertussis intoxication. The changes in both of these parameters occur "late" (12-48 h), as compared to the early events that occur within 5 h. Pertussis toxin action appears to be composed of two, temporally distinct, groups of effects. Pertussis toxin-catalyzed ADP-ribosylation of G alpha-subunits, attenuation of the inhibitory regulation of adenylate cyclase, and attenuation of the ability of GTP to induce an agonist-specific shift in receptor affinity are members of the early group of effects. The second group of late effects includes the decline in G beta-subunit levels and the progressive enhancement of the stimulatory pathway of adenylate cyclase. This enhanced stimulatory control at these later times cannot be explained by the attenuation of the inhibitory pathway occurring early, but rather appears as G beta-subunit levels decline.
在体外和体内研究了百日咳毒素对G蛋白α和β亚基稳态水平的影响。百日咳毒素催化ADP核糖基化的主要底物Goα的稳态水平,在体外培养的3T3-L1细胞中,长达100小时的百日咳毒素处理,或在体内长达3天的处理后,均未改变。在3T3-L1细胞中,百日咳毒素处理未改变Gsα亚基的水平;在S49细胞中,百日咳毒素处理后Gsα亚基的水平适度下降。相比之下,在体外和体内进行百日咳毒素处理后,发现Gβ亚基的稳态水平下降至正常细胞总量的50%以下。腺苷酸环化酶的抑制性调控、百日咳毒素催化的Giα和Goα的ADP核糖基化,以及激动剂特异性结合β肾上腺素能受体的GTP依赖性转变,在百日咳毒素处理后5小时内减弱或消除,代表了毒素的“早期”效应。相比之下,腺苷酸环化酶的刺激性调控则表现出逐渐增强,在百日咳毒素处理后4小时首次观察到,此后一直增加到100小时,即测量的最后一个时间点。腺苷酸环化酶刺激途径的这种逐渐增强在刺激性受体水平上并未表现出来,因为其中一种受体β肾上腺素能受体的Kd和Bmax在毒素处理的细胞中未发生改变。此外,在由β肾上腺素能激动剂异丙肾上腺素和前列腺素E1刺激的细胞中均观察到腺苷酸环化酶刺激的增强。刺激途径的逐渐增强与百日咳中毒后Gβ亚基水平的下降最相关。与5小时内发生的早期事件相比,这两个参数的变化均发生在“晚期”(12 - 48小时)。百日咳毒素的作用似乎由两组在时间上不同的效应组成。百日咳毒素催化的Gα亚基的ADP核糖基化、腺苷酸环化酶抑制性调控的减弱,以及GTP诱导受体亲和力激动剂特异性转变能力的减弱,均属于早期效应组。第二组晚期效应包括Gβ亚基水平的下降和腺苷酸环化酶刺激途径的逐渐增强。在这些较晚时间的这种增强的刺激性调控不能用早期发生的抑制途径的减弱来解释,而是随着Gβ亚基水平的下降而出现。